First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 12, 2024

Meridian Bioscience Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Net Income (Common) Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Net Income (Common)
$42.5m
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Net Income (Common)
$290.8m
CAGR 3-Years
-49%
CAGR 5-Years
-4%
CAGR 10-Years
0%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Net Income (Common)
-$95m
CAGR 3-Years
N/A
CAGR 5-Years
38%
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Net Income (Common)
$462.2m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
13%
Lantheus Holdings Inc
NASDAQ:LNTH
Net Income (Common)
$460.5m
CAGR 3-Years
N/A
CAGR 5-Years
61%
CAGR 10-Years
N/A

See Also

What is Meridian Bioscience Inc's Net Income (Common)?
Net Income (Common)
42.5m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Net Income (Common) amounts to 42.5m USD.

What is Meridian Bioscience Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
15%

Over the last year, the Net Income (Common) growth was -41%. The average annual Net Income (Common) growth rates for Meridian Bioscience Inc have been 20% over the past three years , 15% over the past five years .